Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: Effect of Exercise, Endocannabinoids and Ketones on Cerebral Metabolism in a Cognitive Disorders Population [NA]
A completed clinical trial studied the effects of exercise, endocannabinoids, and ketones on cerebral metabolism in individuals with cogniti…
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: BRain Energy Activation With Ketones to Prevent Alzheimer's Disease [NA]
A completed clinical trial assessing brain energy activation with ketones to prevent Alzheimer's disease in individuals with mild cognitive …
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: Rocky Mountain Alzheimer's Disease Center Longitudinal Biomarker and Clinical Phenotyping Study
This ClinicalTrials.gov update reports termination of the Rocky Mountain Alzheimer's Disease Center Longitudinal Biomarker and Clinical Phen…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: ALFAsleep: Exploring Cognitive and Biological Correlates of Sleep Quality and Their Potential Links With Alzheimer's Disease
The ALFAsleep study, completed, investigates how sleep quality relates to cognitive function and biological markers and explores potential l…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: Longitudinal Study for the Characterization of the Phases of Subjective Perception of Cognitive Decline and Mild Cognitive Impairment of Alzheimer's Disease.
A longitudinal study to characterize the phases of subjective perception of cognitive decline and mild cognitive impairment in Alzheimer's d…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: Brain Characterization of Amyloid Protein and Glucose Metabolism of ALFA Project Participants
Ongoing clinical trial updating brain amyloid and glucose metabolism profiles in ALFA project participants to deepen understanding of Alzhei…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: β-AARC: Cohort Study for the Identification of Blood-based Biomarkers in a Population With Subjective Cognitive Decline
A cohort study sponsored by Barcelonabeta Brain Research Center and Pasqual Maragall Foundation to identify blood-based biomarkers in indivi…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: ADvanced ALzheimer Disease and Effects of Protologic and LAnguage Rehabilitation Tools in Nursing Home (ADALPA) [NA]
A clinical trial named ADALPA to evaluate Protologic and Language Rehabilitation Tools for advanced Alzheimer’s disease in nursing homes; th…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: Exploring the Utility of [18F]3F4AP for Demyelination Imaging [Phase 1]
Phase 1 study investigating the PET radiotracer [18F]3F4AP for imaging demyelination. The trial is currently recruiting and aims to assess i…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: Early Identification of Markers in Alzheimer's Families / ALFA
ALFA study update (NCT02485730) from Barcelonabeta Brain Research Center and Pasqual Maragall Foundation focuses on early identification of …
-
CLINICAL_TRIALS trial_result · 2025-05-30Clinical Trial Update: Assessment of the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type [Phase 3]
Phase 3 trial evaluating AVP-786 for agitation in Alzheimer's disease dementia has been terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-05-30Clinical Trial Update: Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type [Phase 3]
Phase 3 trial of AVP-786 for agitation in Alzheimer's-type dementia was terminated; results have been posted (2025-05-30).
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Lifestyle for the BRAin Health - Nutrition and Exercise Training Intervention [NA]
A clinical trial update indicates the Lifestyle for BRAin Health study is currently recruiting. The study will evaluate nutrition and exerci…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: German Validation Study of the Subjective Cognitive Decline Questionnaire (SCD-Q) [NA]
German validation study of the Subjective Cognitive Decline Questionnaire (SCD-Q) in populations with Alzheimer's disease and subjective cog…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Methodology Issues in a Tailored Light Treatment for Persons With Dementia - Aim 2 [NA]
This clinical trial update describes methodological issues in Aim 2 of a tailored light therapy study for persons with Alzheimer's disease a…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Human Mesenchymal Stem Cells (hMSC) in Behavioral Problems Due to Alzheimer's Disease. [Phase 2]
Phase 2 clinical trial investigating human mesenchymal stem cells for behavioral problems, including agitation, in Alzheimer's disease; curr…
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: Deep Cervical Lymphaticovenous Anastomosis Surgery for Moderate-to-Advanced Dementia Patients [NA]
Clinical trial update for deep cervical lymphaticovenous anastomosis surgery in moderate-to-advanced dementia patients; the study is not yet…
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: Effectiveness of a 3-month Individual Reminiscence Therapy Program in Older Adults With Alzheimer's Disease [NA]
Clinical trial update on the effectiveness of a 3-month individual reminiscence therapy program for older adults with Alzheimer's disease. T…
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: HOme-based Brain Monitoring With a GARment-EEG to Study Cognitive Decline in the Aging Population
Clinical trial evaluating a garment-based EEG system for home brain monitoring to study cognitive decline in aging adults; recruitment is cu…
-
CLINICAL_TRIALS trial_result · 2025-05-25Clinical Trial Update: Use of a Cannabinoids as a Treatment Strategy for Alzheimer's Disease [Phase 2]
Phase 2 clinical trial evaluating cannabinoids as a treatment strategy for Alzheimer's disease has been completed, with results reported.
-
CLINICAL_TRIALS trial_result · 2025-05-25Clinical Trial Update: Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease [Phase 3]
The Phase 3 trial of simufilam 100 mg for mild-to-moderate Alzheimer's disease has completed, with results posted on 2025-05-25.
-
CLINICAL_TRIALS trial_result · 2025-05-25Clinical Trial Update: Ultrasonic Neuromodulation for Treatment of Cognitive Impairment [Phase 1, Phase 2]
A University of Utah-sponsored clinical trial evaluated ultrasonic neuromodulation for cognitive impairment, including Alzheimer's disease a…
-
CLINICAL_TRIALS withdrawal · 2025-05-25Clinical Trial Update: Clinical Trial of AGB101 for Mild Cognitive Impairment [Phase 2]
Phase 2 trial of AGB101 for Mild Cognitive Impairment and prodromal Alzheimer's disease has been withdrawn.
-
EMA safety_alert · 2025-05-23EMA starts review of ipidacrine-containing medicines
EMA has started a review of medicines containing ipidacrine to evaluate their effectiveness for authorised uses and to assess potential live…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: VR-based Physical Activity and Reminiscence Therapy [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trial evaluating a virtual reality-based physical activity and reminiscence therapy for dementia and mild cognitive…